MicroPlex) (Micro Vention, Inc) were deployed into aneurysmal sac. FRED flow diverter (MicroVention, Inc) (4×44 mm) was deployed across aneurysm neck from the M1 segment of right MCA to the distal cavernous ICA on the right side. Check injection showed patency of FRED with slowing of circulation in the aneurysm sac (Fig. 1) . Intravenous infusion of Tirofiban was given at 0.4 μ g/kg/min for 30 minutes followed by 0.1 μ g/ kg/min for 18 hours.
On 2nd post-op day (48 hours post-procedure)-Patient developed weakness of left side with altered sensorium and was immediately shifted to DSA which showed kinking of flow diverter at the neck of the aneurysm with poor distal flow (Fig. 2) . It was planned to perform balloon angioplasty at the site of the kink. It was attempted to manipulate a microcatheter and microguidewire distal to the kink; however, it was not possible to negotiate even the microguidewire through the kinked flow diverter. Antiplatelet was continued and patient was kept on observation.
On 5th post-op day -Patient worsened in sensorium (E1M3VT) and MRI done showed multifocal infarcts in right MCA territory. At this stage, anti-platelet medications were discontinued seeing the risk of hemorrhagic transformation of infarct and was taken for emergency decompressive hemicraniectomy. She improved to M4 status with persisting pupillary asymmetry and left sided paucity of movements. Subsequent CT scans revealed right MCA infarct. The neurological status at discharge is E4M3. The patient has shown gradual improvement over time and at present, has a modified Rankin score of 4. 
DISCUSSION
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Extrusion, Montmorency, France) and (Pipeline Embolization Device) PEDs (ev3/Covidien, Irvine, CA, USA), the treatment of giant aneurysm has changed rapidly. Flow-diverting devices represent a significant advancement in endovascular remodelling strategies of aneurysm treatment. 1 The mechanism of action of flow diverters is based on two concepts: firstly, by disruption of blood flow from parent artery into the aneurysm, and secondly, by providing a scaffold for endothelial cells to growthereby isolating the aneurysm from parent artery. 2 Following deployment of flow diverter, the aneurysm gradually begins to thrombose, and eventually shrinks and collapses around the device construct. 3 Over a period of 6-12 months, as endothelialisation gradually progresses and aneurysmal thrombosis continues, parent vessel is reconstructed with aneurysmal occlusion and resorption of the thrombus. [4] [5] [6] The metallic surface area coverage of flow diverters is approximately 30-50% of the total surface area of the aneurysm neck and the porosity is 60-76% as compared with 89% porosity in stents used in stentassisted coiling. This optimal balance between porosity and pore density allows preservation of perforators and small branches, while achieving aneurysmal thrombosis, reduction in rupture risk and recanalization rates of treated aneurysms.
The FRED flow diverter is a closed-cell, paired-stent flow diversion device and is currently CE-Marked in Europe. FRED has a unique integrated dual-layer (stent-within-a-stent) design with an outer, highporosity stent composed of 16 nitinol wires and an inner, low-porosity, flow-diverting mesh composed of 48 braided nitinol strands. This integrated dual-layer coverage offers enhanced radial force with the 48-wire inner stent layer providing 22% to 44% metal coverage. If the device is not correctly positioned across the aneurysm neck, the pusher allows resheathing and 
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repositioning of the stent as long as ≤80% of its length has been unsheathed/deployed. In a study conducted by Diaz et al. 7 , the FRED system was technically easy to deploy with no procedural complications occurring in this f irst reported series of 14 aneurysms. The ability of the FRED system to be recaptured after partial deployment and to maintain its internal shape in tortuous vessels was well demonstrated.
In our case, FRED flow diverter (4×44 mm) was deployed across aneurysm neck from the M1 segment of MCA to the distal cavernous ICA on the right side. Before the placement of flow diverter, few long coils were deployed to augment thrombosis of the aneurysm. Subsequent angiogram showed patency of FRED with slowing of circulation in the aneurysm sac. We could observe filling of all the branches of the right ICA on post-procedure angiogram. Tirofiban infusion was continued for 18 hours post-procedure to minimise the risk of thrombo-embolic complications. The patient was neurologically intact for 48 hours after the procedure. On the 2nd post-op day, patient developed weakness of left side with altered sensorium and was immediately shifted to DSA which showed kinking of flow diverter at the neck of the aneurysm with poor distal flow.
The likely cause of development of kink is because the aneurysm was wide-necked, the hemodynamic forces have resulted in inward buckling of the flow diverter at the aneurysm neck. It could have been prevented by: packing the aneurysm with more coils thereby providing a scaffold against which the flow diverter would be supported or by deploying a longer length braided stent like LEO (Balt Extrusion, Montmorency, France) or LVIS (MicroVention, Inc) initially and then deploying the flow diverter within it.
